Appco Pharma LLC recalls

3 recalls.

• Prazosin Hydrochloride Capsules recall (Appco Pharma LLC)
  DrugClass IIReported April 8, 2026 · cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
• Prazosin Hydrochloride Capsules recall (Appco Pharma LLC)
  DrugClass IIReported April 8, 2026 · cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
• Prazosin Hydrochloride Capsules recall (Appco Pharma LLC)
  DrugClass IIReported April 8, 2026 · cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.